Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share Attributable to Common Stockholders (Tables)

v3.23.3
Net Income (Loss) Per Share Attributable to Common Stockholders (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders
The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share data):
Three Months Ended
September 30,
Nine Months Ended
September 30,
Basic net income (loss) per share:
2023 2022 2023 2022
Numerator:
Net Income (loss) attributable to common stockholders
$ 1,525  $ (79,206) $ (397,947) $ (191,099)
Denominator:
Basic weighted-average shares outstanding
672,559,810  583,970,409  638,388,011  581,458,391 
Basic net income (loss) per share attributable to common stockholders
$ 0.00  $ (0.14) $ (0.62) $ (0.33)
Diluted net income (loss) per share:
Numerator
Net Income (loss) attributable to common stockholders
$ 1,525  $ (79,206) $ (397,947) $ (191,099)
Less:
Income attributable to participating securities(1)
$ (46) —  —  — 
Diluted net income (loss) attributable to common stockholders 1,479  (79,206) (397,947) (191,099)
Denominator:
Number of shares used in basic net income (loss) per share computation 672,559,810  —  583,970,409  —  638,388,011  —  581,458,391 
Weighted-average dilutive securities 18,895,352  —  —  —  — 
Diluted weighted-average common stock outstanding 691,455,162  583,970,409  638,388,011  581,458,391 
Diluted net income (loss) per share attributable to common stockholders $ 0.00  $ (0.14) $ (0.62) $ (0.33)
(1) Participating securities include Earnout shares, unvested early exercised options and unvested restricted stock awards.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods presented because including them would have been antidilutive:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023 2023
Common stock warrants 28,783,333  28,783,333 
Unvested restricted stock units 3,596,979  29,342,561 
Options to purchase common stock and unvested restricted stock awards 3,959,867  18,216,147 
ESPP —  1,042,062 
Total 36,340,179  77,384,103 
Three and Nine Months Ended September 30, 2022
Common stock warrants 28,783,333 
Unvested restricted stock units 23,201,266 
Options to purchase common stock and unvested restricted stock awards 25,145,381 
Earnout Shares 17,130,000 
Total 94,259,980